Prakash Nallathamby has been named a 2026 recipient of the University of Notre Dame IDEA Center’s Research Commercialization Grant (RCG), alongside bioengineering doctoral student Aurelie Brownsberger. The RCG program provides targeted, translational funding designed to accelerate the real-world impact of Notre Dame research by advancing the commercial readiness of promising University inventions. The award recognizes …
Tag Archive: Berthiaume Institute for Precision Health
May 09
AY 2026 in Review: PD[N]ano Lab Highlights Featured in the Provost’s TPAC-RL May 2026 Newsletter
The Provost’s TPAC-RL Faculty Newsletter (Spring 2026) went out this week, and I’m grateful that several of the lab’s milestones from the past academic year were included in the round-up of faculty achievements. The newsletter is sent to the university’s Teaching, Professor of the Practice, Advising, Clinical, Research, and Library faculty community, and it’s a …
May 09
Aurelie Brownsberger Leads a Student Cohort in a Journal of Nanotheranostics Invited Feature Review on Intrinsically Selective Therapeutic Nanoplatforms
I am thrilled to share that our invited Feature Review — led by graduate researcher Aurelie Brownsberger as lead author with significant contributions from undergraduate researchers in our group— is now published in MDPI’s Journal of Nanotheranostics (JNT), as part of the Special Issue: Feature Review Papers in Nanotheranostics. Title: Intrinsically Selective Nanoplatforms for Precision …
Apr 20
From the Bench to the Big Picture: Kendall Bradley Earns ACS Honors at the 2026 Hoosier Science and Engineering State Fair and Returns to the Lab for Senior Year!
A few weeks ago, I shared the news of Kendall Bradley’s outstanding performance at the Northern Indiana Regional Science and Engineering Fair (NIRSEF). I am thrilled to follow up with another reason to celebrate. At the Hoosier Science and Engineering Fair / Indiana State Science Fair, Kendall earned the 2nd Place Award from the American …
Mar 17
It’s Official: U.S. Patent No. 12,576,160 Issued for Our Bispecific Bridge Nanoparticle Technology
I am delighted to share that on March 17, 2026, the United States Patent and Trademark Office officially issued U.S. Patent No. 12,576,160 for our technology, “Bispecific bridge nanoparticles for efficient targeting of cancer cells using immunotherapy (universal CAR-T cells) or chemotherapeutic” (Notre Dame docket P21-043-US01). This is the same invention that received its Notice …
Mar 10
A Busy Week in Raleigh: TechConnect World 2026 — Two Chaired Sessions, Two Oral Talks, and a BactiBlank Finalist Pitch
I had the privilege of representing the PD[N]ano Lab and the Berthiaume Institute for Precision Health at the 29th Annual TechConnect World Innovation Conference and Expo, held March 10–12, 2026 at the Raleigh Convention Center and the Raleigh Marriott City Center in Raleigh, North Carolina. It was a packed three days — between chairing sessions, …
Mar 04
Celebrating Excellence: Kendall Bradley Shines at NIRSEF 2026!
I am incredibly proud to announce the outstanding achievements of our student researcher, Kendall Bradley, a junior at Marian High School. At the recent Northern Indiana Regional Science and Engineering Fair (NIRSEF) (Feb 28, 2026), Kendall’s hard work, analytical rigor, and dedication paid off in a big way. She took home a 2nd Place Ribbon, …








Recent Comments